ที่ FPI Ref. FPI.024/2018 12 November 2018 Subject : Management Discussion & Analysis of Performance Results of Quarter 3/2018 To : Board of Directors and President of The Stock Exchange of Thailand
October 11, 2019 Re: Clarification of the operating results of company and its subsidiaries for the nine month periods ended September 30, 2018 To: Boards and Managements The Stock Exchange of
ที่ FPI Ref. FPI.007/2020 15 July 2020 Subject : Management Discussion & Analysis of Performance Results of Quarter 1 2020 To : Board of Directors and President of The Stock Exchange of Thailand
ที่ FPI Ref. FPI.008/2020 11 August 2020 Subject : Management Discussion & Analysis of Performance Results of Quarter 2 2020 To : Board of Directors and President of The Stock Exchange of Thailand
August 11, 2020 Subject: Management’s Discussion and Analysis for the second Quarter of 2020 To: The President The Stock Exchange of Thailand (SET) DOD Biotech Public Company Limited and its subsidiaries
Flow 30.10 63.82 -45.13 47.95 Financing Cash Flow -125.85 -231.15 18.78 -124.63 Net Cash Flow -12.64 -29.61 -26.26 108.89 Statement of Financial Position (MB.) 2021 (01/01/21 -31/12/21) 2020 (01/01
Investing Cash Flow 34.63 -21.38 12.46 -40.44 Financing Cash Flow 478.94 -116.00 45.04 -9.18 Net Cash Flow 528.27 11.90 47.18 31.93 Statement of Financial Position (MB.) 2021 (01/01/21 -31/12/21) 2020 (01
MDE02_5 Feb 17 (Translation) No.3/2018 February 6, 2018 President The Stock Exchange of Thailand Re: Notification of the Resolution of the Board of Directors’ Meeting No. 2/2018 We, AEON Thana Sinsap
Ref.No.1905/026EN July 16, 2019 Subject Inform about The Connected Transaction Attention President of the Stock Exchange of Thailand According to the Board of Directors Meeting No.9/2019 of UBIS